Douglas Pharmaceuticals

Get the latest jobs and industry news

Today’s drug development pipelines are increasingly shaped by poorly soluble, lipophilic molecules. Formulation strategy matters more than ever. This article highlights why softgel capsules are gaining traction. Not just as a delivery format, but as a way to effectively address some of the industry’s biggest challenges. From improving bioavailability and stability of complex APIs, to supporting patient adherence and creating more differentiated products, softgels can play a critical role in unlocking value across the lifecycle. Worth a read if you're working with molecules where solubility and bioavailability are making the path to commercial success more challenging. https://lnkd.in/gXBp3Xmk

At Douglas CDMO, scientific rigour meets focused expertise in oral drug delivery. We work closely with you to navigate complexity and keep your program moving forward.

At Douglas CDMO, our proven track record speaks volumes. We combine deep technical knowledge with an unwavering focus on partnership to deliver exceptional results in oral drug development.

From early development through to scale-up, success depends on how well the details are understood. Our teams bring the depth and focus needed to turn complexity into meaningful progress.

Progress comes from precision. Douglas CDMO applies a focused approach to softgel and lipid-based formulation, supporting your program from development through to commercial readiness.